Botox for the Treatment of Recurrent Chronic Exertional Compartment Syndrome
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether Botox injections can reduce pain in patients with R-CECS who still have pain after surgery. Botox works by stopping the muscles from contracting too much, which helps to lower pain and pressure.
Who Is on the Research Team?
Michael Suer, MD
Principal Investigator
University of Wisconsin, Madison
Are You a Good Fit for This Trial?
Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Initial Clinic Visit
Baseline measurements and Botox injection are administered
Treatment Follow-up
Follow-up visit to assess ankle strength and monitor side effects
Extended Follow-up
Telephone follow-up assessments of UWRI at 4 and 6 months
What Are the Treatments Tested in This Trial?
Interventions
- Botox
Botox is already approved in United States, European Union for the following indications:
- Overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency
- Urinary incontinence due to detrusor overactivity associated with a neurologic condition
- Overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Wisconsin, Madison
Lead Sponsor